BlackRock’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.7M | Sell |
|
|||||
|
2025
Q1 | $18.9M | Buy |
|
|||||
|
2024
Q4 | $23.4M | Buy |
|
|||||
|
2024
Q3 | $27.2M | Buy |
|
|||||
|
2024
Q2 | $26.3M | Buy |
|
|||||
|
2024
Q1 | $7.45M | Sell |
|
|||||
|
2023
Q4 | $4.78M | Buy |
|
|||||
|
2023
Q3 | $2.36M | Buy |
|
|||||
|
2023
Q2 | $212K | Sell |
|
|||||
|
2023
Q1 | $317K | Sell |
|
|||||
|
2022
Q4 | $1.61M | Sell |
|
|||||
|
2022
Q3 | $2M | Sell |
|
|||||
|
2022
Q2 | $3.89M | Sell |
|
|||||
|
2022
Q1 | $14.3M | Sell |
|
|||||
|
2021
Q4 | $35.3M | Buy |
|
|||||
|
2021
Q3 | $56.3M | Buy |
|
|||||
|
2021
Q2 | $62.9M | Buy |
|
|||||
|
2021
Q1 | $45.9M | Buy |
|
|||||
|
2020
Q4 | $59.2M | Buy |
|
|||||
|
2020
Q3 | $41.2M | Buy |
|